Asset Management
Compare Stocks
5 / 10Stock Comparison
BENF vs BX vs KKR vs APO vs CG
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management - Global
Asset Management
BENF vs BX vs KKR vs APO vs CG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management - Global | Asset Management |
| Market Cap | $1.86B | $95.85B | $89.45B | $73.67B | $17.70B |
| Revenue (TTM) | $-8M | $13.83B | $19.26B | $30.30B | $4.90B |
| Net Income (TTM) | $-50M | $3.02B | $2.37B | $4.48B | $809M |
| Gross Margin | 312.1% | 86.0% | 41.8% | 88.5% | 65.9% |
| Operating Margin | 304.4% | 51.9% | 2.4% | 34.4% | 26.2% |
| Forward P/E | 54.6x | 20.7x | 16.9x | 14.9x | 12.3x |
| Total Debt | $118M | $13.31B | $54.77B | $13.36B | $13.89B |
| Cash & Equiv. | $1M | $2.63B | $6M | $19.24B | $3.21B |
BENF vs BX vs KKR vs APO vs CG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| Beneficient (BENF) | 100 | 0.4 | -99.6% |
| Blackstone Inc. (BX) | 100 | 95.7 | -4.3% |
| KKR & Co. Inc. (KKR) | 100 | 137.6 | +37.6% |
| Apollo Global Manag… (APO) | 100 | 183.9 | +83.9% |
| The Carlyle Group I… (CG) | 100 | 92.2 | -7.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BENF vs BX vs KKR vs APO vs CG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BENF carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 92.0%, EPS growth 100.0%
- 92.0% NII/revenue growth vs KKR's -11.0%
- Beta 0.69 vs CG's 1.88
- +10.1% vs KKR's -13.0%
BX is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 2 yrs, beta 1.53, yield 6.3%
- Beta 1.53, yield 6.3%, current ratio 0.91x
- Efficiency ratio 0.3% vs APO's 0.5% (lower = leaner)
- 6.3% yield, 2-year raise streak, vs KKR's 0.8%, (1 stock pays no dividend)
KKR ranks third and is worth considering specifically for value.
- Lower P/E (16.9x vs 20.7x)
APO is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 7.6% 10Y total return vs KKR's 7.2%
- Lower volatility, beta 1.43, Low D/E 31.4%, current ratio 0.78x
- PEG 0.20 vs BX's 0.99
CG is the clearest fit if your priority is bank quality.
- NIM 7.1% vs KKR's 0.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 92.0% NII/revenue growth vs KKR's -11.0% | |
| Value | Lower P/E (16.9x vs 20.7x) | |
| Quality / Margins | Efficiency ratio 0.3% vs APO's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.69 vs CG's 1.88 | |
| Dividends | 6.3% yield, 2-year raise streak, vs KKR's 0.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +10.1% vs KKR's -13.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs APO's 0.5% |
BENF vs BX vs KKR vs APO vs CG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BENF vs BX vs KKR vs APO vs CG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
APO leads in 2 of 6 categories
BENF leads 1 • BX leads 0 • KKR leads 0 • CG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BENF leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
APO and BENF operate at a comparable scale, with $30.3B and -$8M in trailing revenue. BX is the more profitable business, keeping 21.8% of every revenue dollar as net income compared to BENF's -6.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | -$8M | $13.8B | $19.3B | $30.3B | $4.9B |
| EBITDAEarnings before interest/tax | -$85M | $7.2B | $9.0B | $11.5B | $1.4B |
| Net IncomeAfter-tax profit | -$50M | $3.0B | $2.4B | $4.5B | $809M |
| Free Cash FlowCash after capex | -$44M | $3.5B | $7.5B | $5.4B | -$1.7B |
| Gross MarginGross profit ÷ Revenue | +3.1% | +86.0% | +41.8% | +88.5% | +65.9% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +51.9% | +2.4% | +34.4% | +26.2% |
| Net MarginNet income ÷ Revenue | -6.4% | +21.8% | +12.3% | +14.8% | +16.5% |
| FCF MarginFCF ÷ Revenue | +4.9% | +12.6% | +49.4% | +24.6% | +27.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +103.0% | +41.3% | -1.7% | +16.3% | +68.4% |
Valuation Metrics
APO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 17.6x trailing earnings, APO trades at a 68% valuation discount to BENF's 54.6x P/E. Adjusting for growth (PEG ratio), APO offers better value at 0.23x vs BX's 1.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.9B | $95.8B | $89.4B | $73.7B | $17.7B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $106.5B | $144.2B | $67.8B | $28.4B |
| Trailing P/EPrice ÷ TTM EPS | 54.57x | 31.53x | 42.88x | 17.60x | 22.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.74x | 16.89x | 14.94x | 12.32x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.51x | — | 0.23x | 1.28x |
| EV / EBITDAEnterprise value multiple | — | 14.77x | 20.24x | 5.92x | 21.23x |
| Price / SalesMarket cap ÷ Revenue | — | 6.93x | 4.64x | 2.43x | 3.61x |
| Price / BookPrice ÷ Book value/share | 33.48x | 4.37x | 1.17x | 1.83x | 2.58x |
| Price / FCFMarket cap ÷ FCF | — | 54.93x | 9.39x | 9.89x | 12.98x |
Profitability & Efficiency
Evenly matched — BENF and BX and APO each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
BENF delivers a 89.3% return on equity — every $100 of shareholder capital generates $89 in annual profit, vs $3 for KKR. APO carries lower financial leverage with a 0.31x debt-to-equity ratio, signaling a more conservative balance sheet compared to BENF's 2.12x. On the Piotroski fundamental quality scale (0–9), BENF scores 6/9 vs APO's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +89.3% | +14.3% | +3.2% | +12.1% | +12.0% |
| ROA (TTM)Return on assets | -14.7% | +6.5% | +0.6% | +1.0% | +3.1% |
| ROICReturn on invested capital | -10.0% | +16.1% | +0.3% | +16.0% | +5.2% |
| ROCEReturn on capital employed | -13.1% | +16.9% | +0.1% | +8.8% | +5.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 3 | 4 |
| Debt / EquityFinancial leverage | 2.12x | 0.61x | 0.67x | 0.31x | 1.97x |
| Net DebtTotal debt minus cash | $117M | $10.7B | $54.8B | -$5.9B | $10.7B |
| Cash & Equiv.Liquid assets | $1M | $2.6B | $6M | $19.2B | $3.2B |
| Total DebtShort + long-term debt | $118M | $13.3B | $54.8B | $13.4B | $13.9B |
| Interest CoverageEBIT ÷ Interest expense | -4.75x | 14.12x | 3.29x | 28.98x | 2.05x |
Total Returns (Dividends Reinvested)
APO leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in APO five years ago would be worth $23,514 today (with dividends reinvested), compared to $45 for BENF. Over the past 12 months, BENF leads with a +1010.4% total return vs KKR's -13.0%. The 3-year compound annual growth rate (CAGR) favors APO at 29.2% vs BENF's -83.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -51.6% | -21.3% | -22.0% | -12.5% | -18.9% |
| 1-Year ReturnPast 12 months | +1010.4% | -6.5% | -13.0% | +0.4% | +26.2% |
| 3-Year ReturnCumulative with dividends | -99.6% | +65.9% | +107.7% | +115.8% | +103.7% |
| 5-Year ReturnCumulative with dividends | -99.6% | +59.0% | +76.5% | +135.1% | +23.4% |
| 10-Year ReturnCumulative with dividends | -99.6% | +476.1% | +715.5% | +759.2% | +281.0% |
| CAGR (3Y)Annualised 3-year return | -83.9% | +18.4% | +27.6% | +29.2% | +26.8% |
Risk & Volatility
Evenly matched — BENF and APO each lead in 1 of 2 comparable metrics.
Risk & Volatility
BENF is the less volatile stock with a 0.69 beta — it tends to amplify market swings less than CG's 1.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APO currently trades 81.3% from its 52-week high vs BENF's 35.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.57x | 1.51x | 1.66x | 1.44x | 1.85x |
| 52-Week HighHighest price in past year | $9.96 | $190.09 | $153.87 | $157.28 | $69.85 |
| 52-Week LowLowest price in past year | $0.26 | $101.73 | $82.67 | $99.56 | $39.60 |
| % of 52W HighCurrent price vs 52-week peak | +35.3% | +64.3% | +65.2% | +81.3% | +70.2% |
| RSI (14)Momentum oscillator 0–100 | 49.4 | 54.8 | 52.4 | 64.9 | 55.1 |
| Avg Volume (50D)Average daily shares traded | 295K | 7.1M | 6.5M | 5.2M | 3.2M |
Analyst Outlook
Evenly matched — BX and KKR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BX as "Buy", KKR as "Buy", APO as "Buy", CG as "Buy". Consensus price targets imply 40.7% upside for KKR (target: $141) vs 23.1% for APO (target: $157). For income investors, BX offers the higher dividend yield at 6.30% vs KKR's 0.80%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $156.29 | $141.14 | $157.25 | $64.14 |
| # AnalystsCovering analysts | — | 29 | 27 | 28 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +6.3% | +0.8% | +1.7% | +2.8% |
| Dividend StreakConsecutive years of raises | — | 2 | 6 | 3 | 0 |
| Dividend / ShareAnnual DPS | — | $7.70 | $0.80 | $2.14 | $1.36 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.3% | +0.1% | +1.0% | +3.9% |
APO leads in 2 of 6 categories (Valuation Metrics, Total Returns). BENF leads in 1 (Income & Cash Flow). 3 tied.
BENF vs BX vs KKR vs APO vs CG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BENF or BX or KKR or APO or CG a better buy right now?
For growth investors, Beneficient (BENF) is the stronger pick with 92.
0% revenue growth year-over-year, versus -11. 0% for KKR & Co. Inc. (KKR). Apollo Global Management, Inc. (APO) offers the better valuation at 17. 6x trailing P/E (14. 9x forward), making it the more compelling value choice. Analysts rate Blackstone Inc. (BX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BENF or BX or KKR or APO or CG?
On trailing P/E, Apollo Global Management, Inc.
(APO) is the cheapest at 17. 6x versus Beneficient at 54. 6x. On forward P/E, The Carlyle Group Inc. is actually cheaper at 12. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apollo Global Management, Inc. wins at 0. 20x versus Blackstone Inc. 's 0. 99x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BENF or BX or KKR or APO or CG?
Over the past 5 years, Apollo Global Management, Inc.
(APO) delivered a total return of +135. 1%, compared to -99. 6% for Beneficient (BENF). Over 10 years, the gap is even starker: APO returned +790. 9% versus BENF's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BENF or BX or KKR or APO or CG?
By beta (market sensitivity over 5 years), Beneficient (BENF) is the lower-risk stock at 0.
57β versus The Carlyle Group Inc. 's 1. 85β — meaning CG is approximately 223% more volatile than BENF relative to the S&P 500. On balance sheet safety, Apollo Global Management, Inc. (APO) carries a lower debt/equity ratio of 31% versus 2% for Beneficient — giving it more financial flexibility in a downturn.
05Which is growing faster — BENF or BX or KKR or APO or CG?
By revenue growth (latest reported year), Beneficient (BENF) is pulling ahead at 92.
0% versus -11. 0% for KKR & Co. Inc. (KKR). On earnings-per-share growth, the picture is similar: Beneficient grew EPS 100. 0% year-over-year, compared to -28. 7% for KKR & Co. Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BENF or BX or KKR or APO or CG?
Blackstone Inc.
(BX) is the more profitable company, earning 21. 8% net margin versus -644. 0% for Beneficient — meaning it keeps 21. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BENF leads at 304. 4% versus 2. 4% for KKR. At the gross margin level — before operating expenses — BENF leads at 312. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BENF or BX or KKR or APO or CG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apollo Global Management, Inc. (APO) is the more undervalued stock at a PEG of 0. 20x versus Blackstone Inc. 's 0. 99x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Carlyle Group Inc. (CG) trades at 12. 3x forward P/E versus 20. 7x for Blackstone Inc. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KKR: 40. 7% to $141. 14.
08Which pays a better dividend — BENF or BX or KKR or APO or CG?
In this comparison, BX (6.
3% yield), CG (2. 8% yield), APO (1. 7% yield), KKR (0. 8% yield) pay a dividend. BENF does not pay a meaningful dividend and should not be held primarily for income.
09Is BENF or BX or KKR or APO or CG better for a retirement portfolio?
For long-horizon retirement investors, Apollo Global Management, Inc.
(APO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 7% yield, +790. 9% 10Y return). The Carlyle Group Inc. (CG) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (APO: +790. 9%, CG: +291. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BENF and BX and KKR and APO and CG?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BENF is a small-cap high-growth stock; BX is a mid-cap high-growth stock; KKR is a mid-cap quality compounder stock; APO is a mid-cap high-growth stock; CG is a mid-cap high-growth stock. BX, KKR, APO, CG pay a dividend while BENF does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.